Cheapest GLP-1 Programs 2026: What the Advertised Price Actually Buys
Back to Articles
Research13 min readAugust 8, 2026

Cheapest GLP-1 Programs 2026: What the Advertised Price Actually Buys

We pulled the advertised starting price for all 87 providers in our database where one is published, then checked what each one actually includes. Almost every price under $50 is an introductory rate, a membership that excludes medication, or an insurance-dependent figure. Here is what you actually pay.

By Med Consumer Watch Team
We maintain pricing research on 111 GLP-1 telehealth providers. For this comparison we pulled the advertised starting price from every provider in that set where one is published — 87 of them — and then checked what each figure actually includes. The headline finding: almost every advertised price below $50 is not a price you will ever pay for a month of treatment. Some are first-month introductory rates that expire. Some are membership fees with medication billed separately on top. Some are contingent on insurance covering a brand-name drug. Some require a twelve-month commitment. A handful are genuinely all-inclusive, and those are the ones worth your attention. This page separates the two. Prices verified from our own provider research, current to August 8, 2026. One thing to say before any of it: the cheapest program is not automatically the right program. Cost matters enormously in this category — GLP-1 therapy is expensive and often lasts years — but a provider that never speaks to you, will not name its pharmacy, or cannot be reached when something goes wrong is not a bargain. We flag those cases as we go.

The Three Ways a Cheap Price Is Not Cheap

Before any ranking, understand the three structures that produce a misleading headline. Every low advertised number in this category is one of them. 1. The introductory rate. A low first-month price that reverts afterwards. This is the most common pattern and the most effective, because the cost arrives after you have started titrating and are least inclined to switch. 2. The membership that excludes medication. A monthly fee that buys clinical access only. The medication is billed separately and is usually the larger number by far. A "$39/month" program where the drug costs $299 is a $338/month program. 3. The insurance-dependent price. A figure like "as low as $25/month" that assumes your plan covers a brand-name GLP-1. If it does not — and for weight loss specifically, many plans do not — you pay the full cash price, which can be ten to forty times higher. Here is how those play out in real advertised prices from our database:
  • Provider | Advertised | What it actually is
  • Hello Alpha | $2.63/day (~$79/mo) | Membership; medication billed separately
  • Curex | $9.99 startup | Startup fee only — semaglutide is $149–$249/mo
  • Weight Watchers Clinic | $12/mo | Promotional rate, 50% off on 12-month plans
  • Able | $20/mo medication | Plus a $79/mo healthcare fee — $99/mo all-in
  • Sequence | $25/mo | Membership only, and requires a 12-month commitment; Wegovy $199/mo for two months then $349/mo
  • Zealthy | $25/mo | Brand-name price with insurance; $151/mo quarterly without
  • Ro and Hims | $39 first month | Then $149/mo membership — medication not included
  • GoodRx | $39/mo | Subscription only, plus medication costs
  • Telos Rx | $49 first month | Introductory; post-intro rate is higher
  • Embody | $69/mo | Introductory, listed as "was $299" — confirm the ongoing rate

Read the Sequence line carefully, because it combines two of the three traps at once: a $25 membership that excludes medication, tied to a twelve-month commitment, with Wegovy at $199/month for two months and then $349/month. The advertised number is $25. A year on Wegovy through that program is closer to $4,000 in medication alone. Nothing about that is hidden — it is all published — but the number on the advertisement is not the number in your bank statement.

The single question that cuts through all of this: "What will I pay, in total, in month six, at my maintenance dose, including everything?" Ask it in writing before you enrol. Month six matters because introductory rates have expired by then and you will have titrated up to a dose that many providers charge more for. Any provider that will not answer that question in a sentence is telling you something.

The Genuinely All-Inclusive Options

These are the providers whose advertised price actually covers the consultation, the medication and the shipping, with no separate membership stacked on top. This is a much shorter list than the one above, and it is the list that matters.
  • Provider | All-in price | What is included
  • Measured Health | ~$79/mo (GLP-1 microdose) | All-in microdose option; standard medication runs $149–$449/mo on a $49 membership
  • Able | $99/mo | $20 medication plus $79 healthcare fee, bundled
  • Embody | $119/mo (tirzepatide) | Membership-free; medication, supplies, doctor review and shipping included
  • Coby Health | $159/mo at 0.25mg | No subscription; consultation, prescription, medication and shipping included — but rises to ~$249/mo at 2.4mg
  • Ivím Health | $133/mo tirzepatide | On a six-month package, plus a $75/mo membership on top
  • Found | $99/mo compounded | Notably, pricing stays flat as your dose increases

Microdose options — the ~$79/month figure at the top of that table — are not the same product as a standard GLP-1 course. Microdosing means sub-therapeutic doses relative to the regimens studied in the STEP and SURMOUNT trials, and the clinical evidence base for weight loss at those doses is not the evidence base used to approve these drugs. If a provider's cheapest option is a microdose, understand that you are buying something different, not the same thing cheaper.

Found's flat-as-dose-increases structure deserves specific mention because it is rare and it matters more than it sounds. Most compounded providers price by dose, so your bill rises exactly as you titrate toward the maintenance dose where the drug actually works. Coby Health's own numbers show the effect plainly: $159/month at the 0.25mg starting dose, about $249/month at 2.4mg. That is a 57% increase between the price you signed up at and the price you settle at.

What Cheap Costs You Elsewhere

Price is one axis. Here is what our provider research consistently shows the low-cost end trades away. Clinical contact. The cheapest programs generally use a questionnaire rather than a consultation. Coby Health, for instance, runs a three-minute questionnaire with no video visit required unless state law mandates one. That is genuinely convenient and genuinely less clinical: a form cannot ask a follow-up question about an ambiguous answer. Compare that with Rixa Health, which requires monthly follow-ups for six months, or Found, which includes monthly clinician check-ins. Named pharmacies. Most low-cost compounded providers do not publish which compounding pharmacy fills the prescription. That is the single most useful disclosure a compounded-medication seller can make, and its absence is near-universal at the cheap end. Refund flexibility. Cheap programs tend to have firm terms. Coby charges a $50 non-refundable clinical fee and does not refund shipped orders. That is defensible for dispensed medication, but it means the decision is close to final at checkout. And the thing no price comparison shows: whether it is the right drug at all.

Every compounded GLP-1 in the cheap tier carries the same regulatory caveat, and it is not a technicality. Compounded drugs are not FDA-approved — not reviewed for safety, effectiveness or manufacturing quality before reaching you — and a compounded preparation is not a generic equivalent of Wegovy or Zepbound. Since the tirzepatide shortage resolved in October 2024 and semaglutide in early 2025, compounding these drugs can no longer rest on a shortage. Lawful 503A compounding now requires a documented clinical reason specific to you. Ask your prescriber what that reason is.

One genuine cost-saver that has nothing to do with telehealth pricing: if you have insurance, check your own plan's coverage for brand-name Wegovy or Zepbound before shopping cash-pay programs at all. Found is built around insurance billing and reports most members paying under $30 per visit for clinical care, and runs a Medicare Part D bridge at $50/month. Zealthy advertises brand-name GLP-1s as low as $25/month with insurance. If your plan covers it, an FDA-approved brand-name drug for $25–$50 beats every compounded option on this page on both price and evidence.

The Realistic Monthly Cost, by Route

Pulling it together. These are the bands our research supports for what you actually pay per month, ongoing, at a maintenance dose — not the introductory rate.
  • Route | Realistic ongoing monthly cost
  • Brand-name with good insurance coverage | $25–$50 — the cheapest route that exists, if your plan covers it
  • Medicare Part D via a bridge program | ~$50 — narrow eligibility, but real
  • Compounded, all-inclusive, low tier | $99–$159 — Able, Embody, Found, Coby at starting dose
  • Compounded at maintenance dose | $199–$299 — where most cash-pay patients actually land
  • Membership + compounded medication | $200–$350 — a $49–$75 membership plus $149–$299 medication
  • Brand-name cash-pay via telehealth | $349–$650 — Zepbound via LillyDirect from $349; Wegovy from $650
  • Brand-name cash-pay, no discount | $1,100–$1,599 — Ozempic and Mounjaro around $1,100; Wegovy quoted as high as $1,599

Note the spread on that last pair. The same molecule — semaglutide — appears on this page at $25/month with insurance and at $1,599/month without. That is not a market with rational pricing; it is a market where what you pay depends almost entirely on which door you walk through. Check your insurance first, every time, before assuming cash-pay compounding is your only affordable option.

Budget for the year, not the month. GLP-1 therapy is not a one-month purchase — the trial evidence runs 68 to 72 weeks, and weight regain after stopping is well documented. A $159/month starting price that becomes $249 at maintenance is roughly $2,700 over a year. That is the number to compare against your insurance's out-of-pocket maximum, not the introductory rate.

How We Compiled This

A note on method, because a ranking is only as good as its sourcing. The dataset is our own provider research — 111 GLP-1 telehealth providers we have reviewed individually, of which 87 publish an advertised starting price we could parse. Every figure on this page comes from that research or from the provider's own published pages, checked as noted in each individual review. We did not rank by advertised price, because that would reproduce exactly the distortion this page exists to correct. We separated advertised prices into introductory rates, membership-only fees and insurance-dependent figures, then identified the subset where the advertised number genuinely covers consultation, medication and shipping. Prices in this category change frequently, often monthly, and introductory offers rotate. Every figure here is current to August 8, 2026 and should be verified on the provider's own site before you buy. Where a provider does not publish pricing at all — Rixa Health is one — we say so rather than estimating. We earn affiliate commissions on some but not all of the providers named here. Several of the cheapest options and the insurance-first recommendation earn us nothing. Where our commercial relationships exist, they are disclosed on the individual review pages.

If you want the full picture on any provider named here, each links to its own detailed review with pricing, terms, complaint record and regulatory history. Our best online GLP-1 program ranking weighs cost alongside clinical quality rather than on price alone, and is the better starting point if cost is not your only constraint.

Frequently Asked Questions

What is the cheapest GLP-1 program? On genuinely all-inclusive pricing, the lowest figures in our data are Measured Health's microdose option at about $79/month, Able at $99/month all-in, Found's compounded tier at $99/month, and Embody tirzepatide at $119/month. But the genuinely cheapest route for anyone with coverage is brand-name medication through insurance at $25–$50/month. Why are advertised GLP-1 prices so much lower than what people pay? Three reasons: introductory first-month rates that expire, membership fees that exclude the medication entirely, and prices contingent on insurance covering a brand-name drug. All three are disclosed; none is obvious from an advertisement. Does the price go up as my dose increases? Usually yes. Coby Health, for example, runs about $159/month at the 0.25mg starting dose and about $249/month at 2.4mg. Found is a notable exception — its compounded pricing stays flat as the dose rises. Is compounded semaglutide cheaper than Wegovy? Cash-pay, yes, usually by a wide margin — $99–$299/month against $650–$1,599. But compounded drugs are not FDA-approved, and if your insurance covers brand-name Wegovy, the brand is likely both cheaper to you and better evidenced. Is a cheap GLP-1 program safe? Legality and safety are separate from price. What the cheap tier typically trades away is clinical contact (a questionnaire rather than a consultation), named pharmacies, and refund flexibility. Ask which pharmacy fills your prescription, verify your prescriber's license with your state medical board, and prefer a provider who actually speaks to you if your medical history is complex. What about microdosing to save money? Microdose GLP-1 options are cheaper — around $79/month — but they are not the same product at a lower price. Sub-therapeutic doses are not the regimens studied in the trials that led to approval. Understand you are buying something different. Should I check insurance first? Yes, always. The same molecule appears in this comparison at $25/month with insurance and $1,599/month without. Check your own plan's weight-loss medication coverage before assuming cash-pay is your only route. How current are these prices? Verified to August 8, 2026 from our provider research and the companies' own published pages. Pricing in this category changes frequently — confirm on the provider's site before purchasing.

The Bottom Line

The cheapest advertised GLP-1 price is almost never the cheapest GLP-1 program. Of the 87 providers in our database that publish a starting price, essentially every figure under $50 is one of three things: an introductory rate that expires, a membership fee that excludes the medication, or a price contingent on insurance covering a brand-name drug. A $25 membership attached to $349/month Wegovy on a twelve-month commitment is not a $25 program, and a $9.99 startup fee attached to $149/month semaglutide is not a $9.99 program. The genuinely all-inclusive low tier sits between $99 and $159 a month at starting doses — Able at $99, Found's compounded tier at $99, Embody at $119, Coby at $159 — and most cash-pay patients land between $199 and $299 a month once they reach a maintenance dose, because most providers price by dose. Found's flat-as-dose-increases pricing is the exception worth knowing about. And the cheapest route of all is the one that has nothing to do with any of this. If your insurance covers brand-name Wegovy or Zepbound, you are looking at $25 to $50 a month for an FDA-approved medication — cheaper than every compounded program on this page, with an evidence base compounded preparations do not have. Medicare Part D members should ask specifically about bridge programs at around $50/month. Check that first. It takes one phone call and it is the highest-value ten minutes in this entire process. What the cheap end costs you is clinical contact, named pharmacies and refund flexibility. Those are real trade-offs rather than dealbreakers, but you should make them knowingly. Ask three questions in writing before you pay anyone: what will I pay in total in month six at maintenance dose, which pharmacy fills my prescription, and what happens if I want to stop? We are not healthcare professionals and this is not medical advice. Compounded medications are not FDA-approved and are not reviewed for safety, effectiveness or manufacturing quality before reaching patients. GLP-1 receptor agonists are contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2 — discuss your full medical history with a licensed clinician. Prices verified August 8, 2026 and change frequently; confirm directly with any provider before purchasing. This is an affiliate marketing website and we earn commissions on some, but not all, of the providers named here; see our [disclosure](/disclosure).

Medical Disclaimer

This article is for informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before making decisions about your health or medications. Individual experiences may vary.

Enter to Win a $1,788 CoreAge Rx Gift Card

Enter for a chance to use it toward eligible CoreAge Rx products and services.

The gift card may be applied toward eligible CoreAge Rx products and services. Prescription products additionally require completing the intake process and evaluation by a licensed healthcare provider, who alone decides eligibility and treatment. Winning does not guarantee that you will qualify for a GLP-1 medication or any other prescription treatment.

No purchase necessary. Prescription products require provider evaluation and approval. See Official Rules. Official Rules · Gift Card Terms · Privacy Policy · Terms